First-Line Bendamustine in the Treatment of Chronic Lymphocytic Leukemia Demonstrates Efficacy vs Chlorambucil Without Compromising Quality of Life - ONA

Links shared publicly online about this topic.

675
total visits

First-Line Bendamustine in the Treatment of Chronic Lymphocytic Leukemia Demonstrates Efficacy vs Chlorambucil Without Compromising Quality of Life - ONA

Bendamustine (BEN) should be considered a backbone drug in first-line chemotherapy of patients with advanced chronic lymphocytic leukemia (CLL) due to its significantly greater efficacy compared with chlorambucil (CLB) with no compromise to quality of life (QoL) in this older and potentially comorbid population, follow-up data from the registration trial has found. The data was presented at the 52nd American Society of Hematology Annual Meeting and Exposition.

View full resource at oncologynurseadvisor.com

Tags: Chemotherapy, Leukemia, Chronic Lymphocytic Leukemia, Drug